cobas® SARS-CoV-2 & Influenza A/B Test

Roche gets emergency approval for combination COVID-19, flu A/B test

ID™SARS-Cov-2 / Influenza Triplex, is a ready-to-use RT-PCR kit.

Clinical Performance of the cobas Liat SARS-CoV-2 & Influenza A/B Assay in Nasal Samples

Cobas Liat SARS-CoV-2 and Influenza A / B System

Clinical Performance of SARS-CoV-2 Molecular Tests

Roche 09211101190 - McKesson Medical-Surgical

cobas® SARS-CoV-2 & Influenza A/B Assay

Aptamers as promising nanotheranostic tools in the COVID‐19 pandemic era - Dzuvor - 2022 - WIREs Nanomedicine and Nanobiotechnology - Wiley Online Library

Roche gets FDA EUA status for cobas SARS-CoV-2 & Influenza A/B Test

FDA greenlights combination at-home test for COVID and influenza in children as flu season approaches

Multi-center nationwide comparison of seven serology assays reveals a SARS- CoV-2 non-responding seronegative subpopulation - eClinicalMedicine

cobas® SARS-CoV-2 Test

Frontiers Influenza A, Influenza B, and SARS-CoV-2 Similarities and Differences – A Focus on Diagnosis

cobas® SARS-CoV-2 Qualitative, Nucleic acid test for use on the cobas® 5800/6800/8800 Systems